DHCNL
DIVERSIFIED HEALTHCARE TRUST
NASDAQ · Real Estate · REIT - Healthcare Facilities · US
$20.01
−0.40%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.5B | 1.5B | 1.5B | 1.4B | 1.3B |
| Cost of Revenue | 1.5B | 1.8B | 1.2B | 1.2B | 1.1B |
| Gross Profit | (61.3M) | (245.3M) | 256.4M | 225.3M | 174.5M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 46.5M | 45.5M | 26.5M | 26.1M | 26.4M |
| General & Admin Expense | 46.5M | 45.5M | 26.5M | 26.1M | 26.4M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | (76.8M) | (251.6M) | — | — | 239.3M |
| Total Operating Expenses | (30.3M) | (206.1M) | 26.5M | 26.1M | 265.7M |
| Cost and Expenses | 1.5B | 1.6B | 1.3B | 1.2B | 1.4B |
| Operating Income (EBIT) | (31.0M) | (39.3M) | 229.9M | 199.2M | (91.2M) |
| Non-Operating | |||||
| Interest Income | — | — | 8.9M | 15.5M | 15.9M |
| Interest Expense | 206.2M | 204.5M | 235.2M | 191.8M | 209.4M |
| Net Interest Income | (206.2M) | (204.5M) | (226.3M) | (176.2M) | (193.5M) |
| Other Non-Op Income/Expense | (120.7M) | (244.9M) | (599.6M) | (492.3M) | 76.2M |
| Non-Operating Income (excl Interest) | (85.5M) | 40.4M | 285.0M | 284.1M | (279.5M) |
| EBT (Pre-Tax Income) | (151.7M) | (284.1M) | (369.8M) | (293.1M) | (15.1M) |
| Income Tax Expense | 3.2M | 1.7M | 467.0K | 445.0K | 710.0K |
| Bottom Line | |||||
| Net Income | (152.1M) | (285.9M) | (370.3M) | (293.6M) | (15.8M) |
| Earnings from Cont. Ops | (154.8M) | (285.9M) | (370.3M) | (293.6M) | (15.8M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (152.1M) | (285.9M) | (370.3M) | (293.6M) | (15.8M) |
| Per Share | |||||
| Basic EPS | ($0.64) | ($1.19) | ($1.55) | ($1.23) | ($0.07) |
| Diluted EPS | ($0.64) | ($1.19) | ($1.55) | ($1.23) | ($0.07) |
| Revenue Per Share | $6.14 | $6.40 | $6.24 | $5.90 | $5.39 |
| Shares | |||||
| Basic Shares Outstanding | 241.0M | 240.3M | 239.5M | 238.8M | 238.3M |
| Diluted Shares Outstanding | 241.0M | 240.3M | 239.5M | 238.8M | 238.3M |
| Profitability Metrics | |||||
| EBITDA | 304.8M | 182.3M | 230.0M | 198.9M | 427.8M |
| D&A | 250.3M | 261.9M | 285.1M | 283.8M | 239.5M |
| EBIT | 54.5M | (79.6M) | (55.1M) | (84.9M) | 188.3M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026